Zhu XL - Search Results

1

Hematologic toxicity assessment in solid tumor patients treated with cetuximab: A pooled analysis of 18 randomized controlled trials.

Cui R, Chu L, Liu ZQ, Xiao YY, Zhu XL, Chen YJ, Xu Q. Cui R, et al. Among authors: zhu xl. Int J Cancer. 2016 Jun 1;138(11):2771-3. doi: 10.1002/ijc.30004. Epub 2016 Feb 21. Int J Cancer. 2016. PMID: 26789526 No abstract available.

2

Hematologic toxicity assessment in solid tumor patients treated with cetuximab: a pooled analysis of 18 randomized controlled trials.

Cui R, Chu L, Liu ZQ, Xiao YY, Zhu XL, Chen YJ, Xu Q. Cui R, et al. Among authors: zhu xl. Int J Cancer. 2015 Feb 15;136(4):936-44. doi: 10.1002/ijc.29045. Epub 2014 Jul 8. Int J Cancer. 2015. PMID: 24975040

3

Approaches for Lynch syndrome screening and characteristics of subtypes with mismatch repair deficiency in patients with colorectal carcinoma.

Feng X, Yao Q, Xu Y, Zhang J, Jia L, Wang Q, Cai X, Xu Y, Liu F, Huang D, Sheng W, Bai Q, Zhu X, Zhou X. Feng X, et al. Int J Cancer. 2024 Nov 15;155(10):1780-1791. doi: 10.1002/ijc.35085. Epub 2024 Aug 7. Int J Cancer. 2024. PMID: 39109916

4

Comprehensive analysis of next generation sequencing and ARMS-PCR for detecting EGFR exon 20 insertion (ex20ins) mutations in Chinese non-small cell lung cancer patients.

Xu Y, Jia L, Zhang L, Wang H, Jiang L, Feng X, Wei R, Yao Q, Ren M, Xue T, Li Y, Zhu X, Zhou X, Bai Q. Xu Y, et al. Transl Lung Cancer Res. 2024 May 31;13(5):986-997. doi: 10.21037/tlcr-23-848. Epub 2024 May 28. Transl Lung Cancer Res. 2024. PMID: 38854943 Free PMC article.

5

Clinical features and prognosis of patients with metastatic ocular and orbital melanoma: A bi-institutional study.

Liu X, Yue H, Jiang S, Kong L, Xu Y, Chen Y, Wang C, Wang Y, Zhu X, Kong Y, Zhang X, Qian J, Luo Z. Liu X, et al. Cancer Med. 2023 Aug;12(15):16163-16172. doi: 10.1002/cam4.6273. Epub 2023 Jul 6. Cancer Med. 2023. PMID: 37409486 Free PMC article.

6

Invasive Breast Cancer with HER2 ≥4.0 and <6.0: Risk Classification and Molecular Typing by a 21-Gene Expression Assay and MammaPrint Plus BluePrint Testing.

Bai Q, Lv H, Bao L, Yang Y, Zhang X, Chang H, Xue T, Ren M, Zhu X, Zhou X, Yang W. Bai Q, et al. Breast Cancer (Dove Med Press). 2023 Aug 3;15:563-575. doi: 10.2147/BCTT.S420738. eCollection 2023. Breast Cancer (Dove Med Press). 2023. PMID: 37554155 Free PMC article.

7

Comprehensive analysis of cancer of unknown primary and recommendation of a histological and immunohistochemical diagnostic strategy from China.

Ren M, Cai X, Jia L, Bai Q, Zhu X, Hu X, Wang Q, Luo Z, Zhou X. Ren M, et al. BMC Cancer. 2023 Dec 1;23(1):1175. doi: 10.1186/s12885-023-11563-1. BMC Cancer. 2023. PMID: 38041048 Free PMC article.

8

Recombinant nanocomposites by the clinical drugs of Abraxane^® and Herceptin^® as sequentially dual-targeting therapeutics for breast cancer.

Ding S, Xiong J, Lei D, Zhu XL, Zhang HJ. Ding S, et al. Among authors: zhu xl. J Cancer. 2018 Jan 1;9(3):502-511. doi: 10.7150/jca.22163. eCollection 2018. J Cancer. 2018. PMID: 29483955 Free PMC article.

9

Clinical application of FIGO 2023 staging system of endometrial cancer in a Chinese cohort.

Yu C, Yuan X, Yao Q, Xu Y, Zhou X, Hu X, Yang H, Wang H, Zhu X, Ren Y. Yu C, et al. BMC Cancer. 2024 Jul 18;24(1):862. doi: 10.1186/s12885-024-12633-8. BMC Cancer. 2024. PMID: 39026198 Free PMC article.

10

Evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed, paraffin-embedded tissue of human lung cancer.

Xu Y, Zhang L, Jia L, Ren M, Xue T, Bai Q, Yao Q, Wei R, Zhou X, Zhu X. Xu Y, et al. J Thorac Dis. 2024 Jan 30;16(1):40-50. doi: 10.21037/jtd-23-1293. Epub 2024 Jan 8. J Thorac Dis. 2024. PMID: 38410581 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

990 results

Search Page

Filters